Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...
Pharmaceutical Technology on MSN3d
WuXi XDC and AbTis collaborate on antibody-drug conjugatesThe partnership combines AbTis' AbClick site-selective conjugation platform with WuXi XDC's all-in-one development and ...
Prague headquartered clinical-stage firm SOTIO Biotech, which is owned by the Czech Republic's PPF Group, today announced it ...
Enhertu improved overall survival versus chemotherapy in HER2-positive metastatic gastric cancer, prompting an interim ...
WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.HK), a leading global CRDMO (Contract Research, ...
including ADCs. Its services cover antibody intermediates and other biologics intermediates, chemical payloads and linkers, as well as bioconjugate drug substances and drug products. For more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback